Loma Linda University

Running trials

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  NCT06405087· Phase 3· Takeda· Source

• Recruiting

  Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  NCT06790784· Phase 3· Jaeb Center for Health Research· Source

• Recruiting

  Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  NCT06881784· Phase 3· Revolution Medicines, Inc.· Source

• Recruiting

  A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  NCT06100289· Phase 3· Takeda· Source

• Active, not recruiting

  Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

  NCT06712407· Phase 4· Asahi Kasei Therapeutics, AB· Source

• Recruiting

  A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  NCT06672549· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  NCT06581198· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  NCT06285643· Phase 2· AskBio Inc· Source

• Active, not recruiting

  Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

  NCT05904028· Phase 3· Jaeb Center for Health Research· Source

• Active, not recruiting

  A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

  NCT05911763· Sanofi· Source

• Active, not recruiting

  Evaluation of Tonabersat for DME

  NCT05727891· Phase 2· Jaeb Center for Health Research· Source

• Recruiting

  Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  NCT05438732· VisionCare, Inc.· Source

• Recruiting

  The KinematX Midcarpal Total Wrist Arthroplasty Registry

  NCT05719935· Extremity Medical· Source

• Active, not recruiting

  Fenofibrate for Prevention of DR Worsening

  NCT04661358· Phase 3· Jaeb Center for Health Research· Source

• Recruiting

  Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  NCT04634240· University of British Columbia· Source

• Active, not recruiting

  SELUTION SLR™ 014 In-stent Restenosis

  NCT04280029· M.A. Med Alliance S.A.· Source

• Active, not recruiting

  PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

  NCT04089059· Endotronix, Inc.· Source

• Recruiting

  Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

  NCT04097158· Loma Linda University· Source

• Recruiting

  Stroke Thrombectomy and Aneurysm Registry

  NCT04994756· Medical University of South Carolina· Source

• Active, not recruiting

  A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

  NCT03504397· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Active, not recruiting

  JOURNEY II XR Safety and Effectiveness PMCF

  NCT03136887· Smith & Nephew, Inc.· Source

• Active, not recruiting

  Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

  NCT02584933· Phase 4· Novartis Pharmaceuticals· Source

• Recruiting

  Simple Bone Cysts in Kids

  NCT02193841· Phase 3· The Hospital for Sick Children· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

  NCT02152631· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Plant-based Diets and Risk of Cancer in the Adventist Health Study-2

  NCT03615599· Loma Linda University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• ALS (motor neurone disease)1 recruiting
• Aortic stenosis1 recruiting
• Brain aneurysm1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Diabetic eye disease1 recruiting
• Macular degeneration1 recruiting
• Osteoarthritis1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Withdrawn

  Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications

  NCT06768320· Phase 4· Loma Linda University· Source

• Recruiting

  A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

  NCT06937931· Phase 2· Ipsen· Source

• Completed

  Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

  NCT06164587· Phase 1/2· Inflammasome Therapeutics· Source

• Terminated

  Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  NCT05268289· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor

  NCT05216250· Phase 2· AbbVie· Source

• Completed

  A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton

  NCT04648878· Loma Linda University· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· California Pacific Medical Center Research Institute· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source

• Recruiting

  Functional Assessment in Liver Transplantation

  NCT03228290· University of California, San Francisco· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Sickle cell disease12 works · 0 trials
• Hidradenitis suppurativa6 works · 0 trials